2025-10-14 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc. (HIMS), based on the data you provided.

## Hims & Hers Health Inc. (HIMS) Analysis

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness products and services directly to consumers.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 258.88%
*   **VOO Cumulative Return:** 70.64%
*   **Absolute Divergence:** 188.24%
*   **Relative Divergence:** 67.4 (Indicates HIMS is currently positioned in the upper range of its historical divergence from the S&P 500.)

**Analysis of Alpha, Beta, CAGR, and MDD:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2019-2021  | -42.0%  | 74.4% | -81.0%  | 0.0   | 1.5    |
| 2020-2022  | -19.0%  | 78.6% | -18.0%  | -0.0  | 1.4    |
| 2021-2023  | -65.0%  | 78.6% | -67.0%  | -0.1  | 2.0    |
| 2022-2024  | 119.0% | 79.4% | 98.0%  | -0.0  | 5.5    |
| 2023-2025  | 263.0% | 80.8% | 202.0% | 0.1   | 12.4   |

**Analysis:**

*   **CAGR:** The CAGR (Compound Annual Growth Rate) varies significantly across the periods. Notably, the most recent period (2023-2025) shows a very high CAGR of 263.0%, indicating strong recent growth. However, prior periods show negative CAGRs.
*   **MDD:** The Maximum Drawdown (MDD) remains consistently high across all periods, around 75-80%, indicating substantial risk and volatility.
*   **Alpha:** Alpha generally mirrors the CAGR trend. The most recent period has a very high positive alpha (202.0%), implying HIMS significantly outperformed its benchmark in this timeframe. Earlier periods had negative alphas.
*   **Beta:** Beta values are close to zero or slightly negative, suggesting HIMS's price movements are not strongly correlated with the overall market.
*   **Cap:** Market Cap has increased significantly over time, reflecting the company's growth in value, particularly in the most recent period.

**2. Recent Price Action:**

*   **Current Price:** $54.73
*   **Previous Close:** $53.95
*   **Change:** 1.45%
*   **5-day Moving Average:** $55.99
*   **20-day Moving Average:** $55.43
*   **60-day Moving Average:** $52.25

**Analysis:**

*   The recent price increase of 1.45% indicates a positive short-term movement.
*   The current price is slightly below the 5-day and 20-day moving averages but above the 60-day moving average, suggesting a possible short-term correction after a longer-term uptrend.  The positive change from the previous close likely reflects the "change" information provided.

**3. Technical Indicators & Expected Return:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommendation)
*   **RSI:** 51.65 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.73 (Slightly negative, suggesting potential for upward movement)
*   **Hybrid Signal:** Buy 100% of cash (17 shares - Very Safe - MRI:0.90). Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01).
*   **Recent (20-day) Relative Divergence Change:** -4.5 (Negative - short-term decline)
*   **Expected Return:** 2.5% (Long-term outperformance vs. S&P 500)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI indicates neutral momentum.
*   The negative PPO suggests the stock might be slightly oversold and could see a potential rebound.
*   The negative change in relative divergence confirms the short-term downward trend indicated by the moving averages.
*   A 2.5% expected return suggests positive long-term outlook.

**4. Recent News & Significant Events:**

*   **Upcoming Earnings Announcement (Nov 3, 2025):** This is a key event to watch. The market's reaction to the earnings report will likely significantly impact the stock price.
*   **Zacks Article: HIMS Dips More Than Broader Market:** This suggests underperformance compared to the overall market.
*   **StockStory Article: Why HIMS Stock Is Nosediving:** This indicates potential negative factors impacting the stock.
*   **Investor's Business Daily: Taking Advantage Of Hims & Hers Stock Volatility:** Highlights the stock's volatile nature.
*   **Yahoo Finance Videos:** Focus on the founder's journey and breaking into complex markets, which can be viewed as positive from a long-term growth perspective.

**Analysis:** Recent news paints a mixed picture. The upcoming earnings announcement is a crucial catalyst.  Articles highlighting underperformance and a "nosediving" stock price are concerning, while others suggest capitalizing on volatility.

**4-2. Analyst Opinions:**

*   **Consensus:** Hold (Mean = 2.92)
*   **Target Price:** Average = $47.42, High = $85.00, Low = $25.00

**Analysis:**  Analysts, on average, have a neutral "Hold" rating on the stock. The wide range in target prices ($25.00 - $85.00) indicates considerable uncertainty and differing opinions on the stock's future potential. The average target price of $47.42 is *below* the current price, suggesting potential downside risk based on analyst estimates.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-08-04 | 0.19 | 0.54 B$ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2025-08-04 | 0.06 | 0.32 B$ |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has fluctuated.
*   **Revenue:** Revenue generally shows an upward trend.

**6. Financial Information (Revenue, Profitability, Capital):**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.54B  | 76.39%        |
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-06-30 | $0.56B   | 7.55%   |
| 2025-03-31 | $0.55B   | 9.01%   |
| 2024-12-31 | $0.48B   | 5.46%   |
| 2024-09-30 | $0.44B   | 17.18%  |
| 2024-06-30 | $0.36B   | 3.67%   |

**Analysis:**

*   **Revenue:** Revenue has generally increased over the reported quarters, indicating business growth.
*   **Profit Margin:** Profit margins are consistently high, suggesting strong pricing power and efficient operations.
*   **Equity:** Equity has been increasing, showing a strengthening financial base.
*   **ROE (Return on Equity):** ROE has fluctuated significantly, indicating variable profitability relative to shareholder equity.

**7. Overall Summary:**

Hims & Hers Health Inc. (HIMS) presents a complex picture.  While the stock has significantly outperformed the S&P 500 historically, recent performance is more concerning, with analysts holding a neutral stance. The upcoming earnings announcement is a crucial event. Revenue is growing, and profit margins are strong, but the high volatility and analyst target prices below the current price suggest caution. Short-term technical indicators point towards potential downward pressure, while long-term expectations remain positive.  The company's high growth potential is balanced by significant risks.
